Back to Search
MATTHEW VIVEIROS, MD
MD
Student in an Organized Health Care Education/Training Program
NPI: 1508657065Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training ProgramPrimary
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Research & Publications (20)
Targeting human macrophages for enhanced killing of intracellular XDR-TB and MDR-TB.
PMID 19383188·Int J Tuberc Lung Dis·2009
6-review
SILA 421, an inhibitor of efflux pumps of cancer cells, enhances the killing of intracellular extensively drug-resistant tuberculosis (XDR-TB).
PMID 19155160·Int J Antimicrob Agents·2009
8-other
Demonstration of the activity of P-glycoprotein by a semi-automated fluorometric method.
PMID 19528478·Anticancer Res·2009
7-preclinical
Protein kinase C delta (PKCdelta) interacts with microtubule organizing center (MTOC)-associated proteins and participates in meiotic spindle organization.
PMID 18602096·Dev Biol·2008
7-preclinical
Promising therapy of XDR-TB/MDR-TB with thioridazine an inhibitor of bacterial efflux pumps.
PMID 18781927·Curr Drug Targets·2008
6-review
Efflux-mediated response of Staphylococcus aureus exposed to ethidium bromide.
PMID 18511413·J Antimicrob Chemother·2008
8-other
Thioridazine and chlorpromazine inhibition of ethidium bromide efflux in Mycobacterium avium and Mycobacterium smegmatis.
PMID 18310137·J Antimicrob Chemother·2008
8-other
Demonstration of intrinsic efflux activity of Escherichia coli K-12 AG100 by an automated ethidium bromide method.
PMID 18343640·Int J Antimicrob Agents·2008
8-other
New methods for the identification of efflux mediated MDR bacteria, genetic assessment of regulators and efflux pump constituents, characterization of efflux systems and screening for inhibitors of efflux pumps.
PMID 18781922·Curr Drug Targets·2008
6-review
Potential role of non-antibiotics (helper compounds) in the treatment of multidrug-resistant Gram-negative infections: mechanisms for their direct and indirect activities.
PMID 18180147·Int J Antimicrob Agents·2008
6-review
The TB laboratory of the future: macrophage-based selection of XDR-TB therapeutics.
PMID 18366334·Future Microbiol·2008
6-review
Antibacterial activity of ergosterol peroxide against Mycobacterium tuberculosis: dependence upon system and medium employed.
PMID 17357175·Phytother Res·2007
8-other
Antibiotic stress, genetic response and altered permeability of E. coli.
PMID 17426813·PLoS One·2007
8-other
Prolonged exposure of methicillin-resistant Staphylococcus aureus (MRSA) COL strain to increasing concentrations of oxacillin results in a multidrug-resistant phenotype.
PMID 17276037·Int J Antimicrob Agents·2007
8-other
In vitro and ex vivo activity of thioridazine derivatives against Mycobacterium tuberculosis.
PMID 17239569·Int J Antimicrob Agents·2007
8-other
Phenothiazines as anti-multi-drug resistant tubercular agents.
PMID 17897062·Infect Disord Drug Targets·2007
6-review
Enhanced killing of intracellular multidrug-resistant Mycobacterium tuberculosis by compounds that affect the activity of efflux pumps.
PMID 17218448·J Antimicrob Chemother·2007
6-review
"Non-Antibiotics": alternative therapy for the management of MDRTB and MRSA in economically disadvantaged countries.
PMID 16842219·Curr Drug Targets·2006
6-review
Inducement and reversal of tetracycline resistance in Escherichia coli K-12 and expression of proton gradient-dependent multidrug efflux pump genes.
PMID 16048990·Antimicrob Agents Chemother·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 6200 N LA CHOLLA BLVD
TUCSON, AZ 85741 - Phone
- (520) 742-9000
Quick Facts
- NPI
- 1508657065
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile